Moderna is suing its two major competitors in the market for COVID-19 vaccines, Pfizer and BioNTech, over allegations that the two firms used its patented technology in the development of their mRNA jabs.
Both Moderna's shot and the joint Pfizer-BioNTech jab are mRNA shots - a little-used technology before its introduction to the mainstream during the COVID-19 pandemic. Moderna alleges that the two competing firms copied technology it had patented between 2010 and 2016.
Moderna had previously chosen not to enforce its patent during the rollout of the Covid vaccines in an effort to avoid stifling global jab rates. It then changed its policy in March, now only promising not to enforce its patents in ways that will harm low-and-middle income nations.
Pfizer and BioNTech have been the major winners in the rollout of the shots. Pfizer alone is projected to earn around $32 billion in sales of its shot around the world this year - with the figure likely to increase with the soon-to-be approval of its Omicron-specific shot. The New York City-based firm also reported $36 billion in revenue last year, combining for $68 off of vaccine sales alone.
Moderna follows just behind, projecting $19 billion in global Covid vaccine sales this year. The company says it is not seeking to stop the sale of the Pfizer shot or have it removed from the market - but instead to receive damages for patent infringement.
read more:
https://www.dailymail.co.uk/health/article-11149357/Moderna-SUES-Pfizer-BioNTech.html
Replies